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Abstract We investigated expression levels of Na+,K+-ATPase
K-isoforms and their ATPase activities in human colorectal can-
cer tissue and the accompanying normal mucosa. A decrease in
expression of the K1-isoform protein was observed in all
sampled cancer tissues compared with the normal mucosae.
The level of ouabain (5 WM)-sensitive Na+,K+-ATPase activity
in carcinomas was 81' 5% that of in the normal mucosae. The
mRNA expression of K2- and K4-isoforms was decreased in
almost all the carcinoma samples. Interestingly, the expression
level of the K3-isoform protein in the cancer tissue was higher
than that of the normal mucosa. These results indicate that a
decrease in the K1-isoform expression and an increase in the K3-
isoform expression may be associated with colorectal cancer.
. 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The Naþ,Kþ-ATPase is composed of two subunits, the cat-
alytic K-subunit and the glycosylated L-subunit. So far, four
di¡erent K-isoforms (K1, K2, K3 and K4) and three di¡erent L-
isoforms (L1, L2 and L3) have been identi¢ed in mammalian
cells [1,2].
It has been reported that expression of mRNAs of L-iso-
forms (L1 and/or L2) was decreased in human cancers such as
renal, lung and hepatocellular cancers [3], and that expression
of proteins of the L-isoforms was decreased in human clear-
cell renal cell [4], gastric [5] and bladder [6] cancers. This
down-regulation of L-subunits has been suggested to be asso-
ciated with the loss of tight junctions and epithelial polarity in
the cancer cells [7]. But an exceptional case was reported in
human colon cancer: the expression level of the L1-isoform
protein was increased compared with normal colonic tissue
[5].
So far reported, changes in the expression of the K-subunit
seem to depend on organs or tissues. No signi¢cant change in
the expression of K1-isoform mRNA was observed in human
renal and lung cancers [3], and no change in the expression of
the protein was observed in human clear-cell renal cell cancer
[4]. Decreased expression of K-subunit mRNA [8] and protein
[6] was observed in human gastric and bladder cancers, re-
spectively. To our knowledge, there is no report showing a
change in the K-subunit expression in colon cancer.
Colorectal cancer is one of the major causes of cancer
deaths in the Western world [9,10]. About 80% of colorectal
carcinomas are histologically characterized by good gland for-
mation (epithelial polarity) and varying degrees of di¡erentia-
tion, from well to moderately di¡erentiated [11]. In the preset
study, we investigated whether expression of Naþ,Kþ-ATPase
K-isoforms were altered in human colorectal cancers (well or
moderately di¡erentiated adenocarcinomas), and found that
levels of protein expression of the K1- and K3-isoforms in
the carcinoma were signi¢cantly di¡erent from those of the
accompanying normal mucosa.
2. Materials and methods
2.1. Tissue procurement
Human colorectal specimens of well or moderately di¡erentiated
adenocarcinomas were obtained from surgical resection of 17 Japa-
nese patients (11 males and six females; 66E 3 years) in accordance
with the recommendations of the Declaration of Helsinki and with
ethics committee approval. Informed consent was obtained from all
patients at Toyama Medical and Pharmaceutical University Hospital.
In all cases, control specimens were collected from the accompanying
normal mucosae, which were 5^10 cm distant from the carcinoma.
The cancer tissue and the normal epithelial layer were carefully iso-
lated from the resected colon with scissors and forceps. These samples
were free from serosa and muscularis propria. Blood vessels around
the tissues were carefully removed. Clinical and histological classi¢ca-
tions according to the general rules edited by the Japanese Research
Society for Cancer of the Colon and Rectum were carried out inde-
pendently by three expert pathologists.
2.2. Sodium dodecylsulfate (SDS)^polyacrylamide gel electrophoresis
and Western blotting
Membrane fractions of the human colorectal tissues, human cancer
cell lines and rat whole brain were prepared as described previously
[12]. Membrane preparations (30 Wg of protein) were incubated in a
sample bu¡er containing 2% SDS, 2% L-mercaptoethanol, 10% glyc-
erol and 65 mM Tris^HCl (pH 6.8) at room temperature for 2 min
and applied to the SDS^polyacrylamide gel. Western blotting was
carried out as described previously [12]. A polyclonal anti-Naþ,Kþ-
ATPase K1 antibody (N-15) and a polyclonal anti-Naþ,Kþ-ATPase
K2 antibody (C-16) were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA, USA), and were used at 1:100 dilution. For neg-
ative control, 1 Wg of the anti-K1 or anti-K2 antibody was pre-incu-
bated with 2 Wg of the corresponding blocking peptide (Santa Cruz
Biotechnology). A monoclonal anti-Naþ,Kþ-ATPase K3 antibody
(XVIF9-G10) was obtained from A⁄nity BioReagents (Golden, CO,
USA), and was used at 1:2000 dilution. For negative control, 1 Wg of
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the anti-K3 antibody was pre-incubated with 3 Wg of the blocking
peptide that corresponds to amino acid residues 1^22 of human
Naþ,Kþ-ATPase K3-isoform [13]. Horseradish peroxidase-conjugated
anti-goat immunoglobulin G (1:2000 dilution) or anti-mouse immu-
noglobulin G1 (1:5000 dilution) was used as a secondary antibody.
2.3. Measurement of Na+,K+-ATPase activity
ATPase activity was assayed in 1 ml of a solution containing 30 Wg
of membrane protein, 120 mM NaCl, 15 mM KCl, 3 mM MgSO4,
3 mM ATP, 5 mM NaN3, and 40 mM Tris^HCl, pH 7.4, in the
presence or absence of 5 WM ouabain. After incubation for 10 min
at 37‡C, the reaction was terminated by the addition of ice-cold stop
solution containing 12% perchloric acid and 3.6% ammonium molyb-
date. Inorganic phosphate released was measured from the absor-
bance at 320 nm as described elsewhere [14]. The Naþ,Kþ-ATPase
activity was calculated as the di¡erence between activities in the pres-
ence and absence of ouabain.
2.4. RNA isolation and quanti¢cation of mRNAs
Total RNAs from the human colorectal tissues were prepared by
using the RNAgents Total RNA Isolation System (Promega, Madi-
son, WI, USA). Amounts of mRNAs of the Naþ,Kþ-ATPase K2- and
K4-isoforms were quanti¢ed by real-time polymerase chain reaction
(PCR) (TaqMan assay) using an ABI Prism 7700 sequence detector.
As a control, the amount of L-actin was measured. The speci¢c prim-
ers and the Taqman £uorescent probes (Assays-on-Demand Gene
Expression Products) were obtained from Applied Biosystems (Foster
City, CA, USA).
2.5. Statistics
Results are presented as the meansES.E.M. Di¡erences between
groups were analyzed by one-way analysis of variance, and correction
for multiple comparisons was done using Dunnett’s multiple com-
parison test. Comparison between the two groups was done using
Student’s t-test. Statistically signi¢cant di¡erences were assumed at
P6 0.05.
3. Results and discussion
The catalytic subunit of Naþ,Kþ-ATPase has at least four
isoforms, K1, K2, K3 and K4, each derived from a di¡erent
gene. The K-isoforms exhibit a tissue-speci¢c pattern of ex-
pression (for review, see [1]). The K1-isoform is found in
nearly every tissue and is involved in a housekeeping function
in all cells. The K2-isoform is predominantly expressed in
adipocytes, skeletal muscle, heart and brain. The K3-isoform
is abundant in nervous tissues. The K4-isoform is expressed
exclusively in testis.
First, we examined the protein expression level of Naþ,Kþ-
ATPase K1-isoform. Interestingly, a decrease in the expression
of the K1-isoform protein was observed in 17 of 17 carcino-
mas (100%) compared with the normal mucosae, and the
average score of its expression in the cancer tissues was
0.32-fold that of the normal tissues (n=17; Fig. 1).
It could be deduced that down-regulation of the K1-isoform
results in a decrease of the Naþ,Kþ-ATPase activity in the
carcinoma. In fact, Fig. 2 shows that the ouabain (5 WM)-
sensitive ATPase activities in the carcinomas were signi¢cantly
lower than those of the accompanying normal mucosae. But
the average activity in the carcinomas was still 81 E 5% of that
in the normal mucosae. It is noted that this value of 81% is
surprisingly high when compared with the decreased K1-pro-
tein level of 32% (Fig. 1B). The possibility may be excluded
that the remaining Naþ,Kþ-ATPase K1-subunit in the carci-
noma (Fig. 1) enhanced its ATP hydrolysis activity per mg of
Fig. 1. Decreased expression of protein of the Naþ,Kþ-ATPase K1-
isoform in human colorectal carcinomas. A: Western blotting for
detecting the K1-isoform protein in paired normal mucosa (N) and
adenocarcinoma (T). Typical blots from six patients are shown. Age
(years) and sex (M or F) of the patient, location of each carcinoma
(A, ascending colon; T, transverse colon; S, sigmoid colon; R, rec-
tum), and stage of the carcinoma according to TNM clinical classi¢-
cation (I, II, III or IV) are: No. 1 (43, M, A, I), No. 2 (74, M, A,
III), No. 3 (70, F, T, II), No. 4 (50, F, S, III), No. 5 (73, M, R, II)
and No. 6 (59, F, R, II). The speci¢c band for the K1-isoform (100
kDa) disappeared in the presence of the blocking peptide (BP).
B: Levels of protein expression of the K1-isoform in the carcinoma
(T) are compared with those of the normal mucosa (N). In each
case, the score was calculated using the following equation: Arbi-
trary score = (amount of the K1-isoform protein in the carcinoma)/
(amount of the K1-isoform protein in the normal mucosa). The
score for normal mucosa is normalized as 1 in each case. Averaged
scoresE S.E.M. of carcinomas (n=17) are shown. **Signi¢cantly
di¡erent (P6 0.01).
Fig. 2. Naþ,Kþ-ATPase activity in the colorectal adenocarcinomas
(T) and the accompanying normal mucosae (N). Averaged scores
ES.E.M. (n=17) are shown. *Signi¢cantly di¡erent (P6 0.05).
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protein, because the Naþ,Kþ-ATPase molecule is known to be
transformed to a regime of decreased e⁄ciency in the presence
of low ATP concentrations which is typical for tumor cells
[15]. In the distal colon of mice treated with the carcinogen
1,2-dimethylhydrazine, the maximum pump rate of Naþ,Kþ-
ATPase was depressed [16]. This depression could result from
changes such as altered molecular structure of the Naþ,Kþ-
ATPase, decreased membrane £uidity or decreased energy
supply or utilization by the pump [16]. Therefore, we assumed
the possibility that the expression of other K-isoform(s) may
be up-regulated in human colorectal carcinomas.
No signi¢cant expression of K2-isoform protein was ob-
served in any of the colorectal carcinomas and accompanying
normal mucosae (Fig. 3A). Real-time PCR (TaqMan assay)
showed that expression of K2-isoform mRNA in the carcino-
mas decreased in 17 out of 17 carcinomas (100%) compared
with the normal mucosae, and the average score of its expres-
sion in the cancer tissues was 0.19E 0.05-fold that of the nor-
mal tissues (P6 0.01; n=17). Real-time PCR also showed
that expression of K4-isoform mRNA decreased in 14 out of
17 carcinomas (82%) compared with the normal mucosae, and
the average score of its expression in the cancer tissues was
0.56E 0.11-fold that of the normal tissues (P6 0.01; n=17).
Expression of the K4-isoform was not investigated at the pro-
tein level for lack of available antibody.
On the other hand, we found that expression of K3-isoform
protein increased in 13 of 17 carcinomas (76%) compared with
the accompanying normal mucosae. The average score of its
expression in the cancer tissues was 11.8-fold higher than that
of the normal tissues (n=17; Fig. 3B,C). These results suggest
that the K3-isoform but not the K2- or K4-isoform is up-regu-
lated in colorectal carcinoma. In addition, a signi¢cant level
of K3-isoform protein was consistently detected in human co-
lonic adenocarcinoma cell lines such as KM12-L4, T-84, HT-
29 and WiDr (Fig. 4). No signi¢cant expression of the K3-
isoform protein was observed in the tissues of human normal
kidney and renal carcinoma (not shown). Concerning the ex-
pression of K3-isoform in epithelial cells, human lens epithelial
cells showed a signi¢cant expression of the protein [17].
Our present results suggest that a decrease in the K1-iso-
form expression and an increase in the K3-isoform expression
may be associated with human colorectal cancer. It is likely
that Naþ,Kþ-ATPase K3-isoform is up-regulated to make up
for the decreased expression of the K1-isoform in colorectal
cancer cells. Crambert et al. [18] have reported that the cata-
lytic K3-isoform can be assembled with the L1-isoform which
is up-regulated in human colon carcinoma [5], and that the
K3^L1 complex expressed in Xenopus oocytes is functionally
active. Intracellular Naþ homeostasis plays a crucial role in
generation of the polarized phenotype of epithelial cells [19].
Taken together, this switching mechanism (K1 to K3) may be
Fig. 3. A: No signi¢cant expression of protein of the Naþ,Kþ-ATP-
ase K2-isoform in human colorectal tissues. Western blotting was
performed in paired normal mucosa (N) and adenocarcinoma (T).
Typical blots from six patients are shown. The number written
above each panel corresponds to the number in Fig. 1A. The specif-
ic band for the K2-isoform of rat brain (100 kDa) disappeared in
the presence of the blocking peptide (BP). B: Increased expression
of protein of the Naþ,Kþ-ATPase K3-isoform in human colorectal
carcinomas. Western blotting was performed in paired normal mu-
cosa (N) and adenocarcinoma (T). Typical blots from six patients
are shown. The number written above each panel corresponds to
the number in Figs. 1A and 3A. The speci¢c band for the K3-iso-
form (110 kDa) disappeared in the presence of the blocking peptide
(BP). C: Levels of protein expression of the K3-isoform in the carci-
noma (T) are compared with those of the normal mucosa (N). In
each case, the score was calculated using the following equation:
Arbitrary score = (amount of the K3-isoform protein in the carcino-
ma)/(amount of the K3-isoform protein in the normal mucosa). The
score for normal mucosa is normalized as 1 in each case. Averaged
scoresE S.E.M. of carcinomas (n=17) are shown. *Signi¢cantly dif-
ferent (P6 0.05).
Fig. 4. Expression of proteins of the K1-isoform (upper panel), K2-
isoform (middle panel) and K3-isoform (bottom panel) in human co-
lonic adenocarcinoma cell lines (KM12-L4, T-84, HT-29 and
WiDr). In left panels, speci¢c bands for the K1-isoform (100 kDa),
K2-isoform (100 kDa) and K3-isoform (110 kDa) are observed.
These bands disappeared in the presence of the corresponding
blocking peptide (BP) (right panels).
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important to maintain the gland structure (epithelial polarity)
of well or moderately di¡erentiated adenocarcinomas in the
human colorectum. At present, the molecular mechanism for
the switching is unknown and is an interesting subject to be
clari¢ed in a future study.
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